Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

R&D incentives excluded from McCain "corporate welfare commission" legislative proposal.

Executive Summary

R&D EXPENDITURES WOULD BE EXEMPTED FROM FEDERAL SUBSIDY REVIEW under legislation introduced Jan. 28 by Sen. McCain (R-Ariz.) and a bipartisan group of eight co-sponsors. The "1997 Corporate Subsidy Reform Commission Act" (S 207) would "establish a nine-member independent commission to comprehensively review, reform and terminate inequitable federal subsidies to profit-making industries, and to establish Congressional procedures to consider the commission's proposal."

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel